NASDAQ:BTMD - Nasdaq - US0906831039 - Common Stock - Currency: USD
biote Corp. (BTMD) delivered earnings and revenue surprises of 33.33% and 3.51%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: MGNX
Cerus (CERS) delivered earnings and revenue surprises of 20% and 2.95%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: CERS
InMode (INMD) delivered earnings and revenue surprises of -6.06% and 0.61%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: INMD
BTMD stock results show that Biote missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
BTMD stock results show that Biote missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
We recently published a list of 10 Micro-Cap Stocks Insiders Were Buying In Q1 2025. In this article, we are going to take a look at where biote Corp. (NASDAQ:BTMD) stands against other micro-cap stocks insiders were buying in Q1 2025. The White House announced Tuesday that Trump’s tariffs would take effect immediately after being […]
We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where InflaRx (NASDAQ:IFRX) stands against other best German stocks to buy according to hedge funds. Germany’s economy is facing continued weakness. According to a report published by Roland […]
We recently published a list of 10 Micro-Cap Stocks Insiders Were Buying In Q1 2025. In this article, we are going to take a look at where Auburn National Bancorporation, Inc. (NASDAQ:AUBN) stands against other micro-cap stocks insiders were buying in Q1 2025. The White House announced Tuesday that Trump’s tariffs would take effect immediately […]
Biote: Revolutionizing Hormone Optimization Biote (NYSE: BTMD) represents an innovative play in the growing hormone optimization market.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biote (NASDAQ:BTMD) just reported results for the second quarter of 2024.Biote ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biote (NASDAQ:BTMD) just reported results for the first quarter of 2024.Biote r...
Biote (BTMD) plans to repurchase all shares owned by founder Gary Donovitz, resolving outstanding litigation and investing $76.9M over three years.